The following is a partial timeline of antidepressant-related meetings of
and alerts issued by the U.S. Food and Drug Administration (FDA) in the past
four years. See "Impact of Label Warnings Felt Beyond Target
Groups" for more information:
Download citation file:
Please confirm that your email address is correct, so you can successfully receive this alert.
Read this week's Update
Sign Up for Psychiatric News Update newsletter